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Syncope is among the most frequent forms of transient loss of consciousness (TLOC), and
is characterized by a relatively brief and self-limited loss of consciousness that by defini-
tion is triggered by transient cerebral hypoperfusion. Most often, syncope is caused by a
temporary drop of systemic arterial pressure below that required to maintain cerebral
function, but brief enough not to cause permanent structural brain injury. Currently,
approximately one-third of syncope/collapse patients seen in the emergency department
(ED) or urgent care clinic are admitted to hospital for evaluation. The primary objective of
developing syncope/TLOC risk stratification schemes is to provide guidance regarding the
immediate prognostic risk of syncope patients presenting to the ED or clinic; thereafter,
based on that risk assessment physicians may be better equipped to determine which
patients can be safely evaluated as outpatients, and which require hospital care. In general,
the need for hospitalization is determined by several key issues: i) the patient's immediate
(usually considered 1 week to 1 month) mortality risk and risk for physical injury (e.g., falls
risk), ii) the patient's ability to care for him/herself, and iii) whether certain treatments
inherently require in-hospital initiation (e.g., pacemaker implantation). However, at pre-
sent no single risk assessment protocol appears to be satisfactory for universal application,
and development of a consensus recommendation is an essential next step.
Copyright © 2015, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V.
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Transient loss of consciousness (TLOC) is a common cause
of emergency department (ED) or urgent clinic visits, and is
an important source of falls and injury, especially in the
elderly. Syncope is among the most frequent forms of TLOC,
and is characterized by a relatively brief and self-limited
loss of consciousness that by definition is triggered by
transient cerebral hypoperfusion. Most often, syncope is
caused by a temporary drop of systemic arterial pressure
below that required to maintain cerebral function, but brief
enough not to cause permanent structural brain injury
[1e4]. In terms of frequency, the combination of ‘syncope
and collapse’ is listed among the top 10 discharge diagnoses
for ED visits based on the most recently available 2011 U.S.
National Hospital Ambulatory Medical Care Survey
(NHAMCS) [5]. Syncope is associated with high direct clinical
and indirect social costs. Among syncope patients seen in
the emergency department (ED) approximately 40% are
hospitalized [6].
Apart from being a common problem, syncope tends to be
both a disconcerting experience for patients and their fam-
ilies, and a difficult condition to evaluate in the ED or clinic.
Since the patient has generally fully recovered by the time
they are seen, the physician often has little in the way of
observable abnormalities to rely upon, and often reports from
eye-witnesses are inadequate. Consequently, given the
resulting uncertainties regarding the cause of the problem,
many of these patients (on average about one-third) are
admitted to hospital for observation and further testing.
However, even when admitted, almost one-half of patients
are discharged without a convincing diagnosis having been
established.
The primary objective of developing syncope/TLOC risk
stratification algorithms is to provide guidance regarding
the immediate prognostic risk of syncope patients present-
ing to the ED or clinic; thereafter, based on that risk
assessment physicians may be better equipped to deter-
mine which patients can be safely evaluated as outpatients,
and which should be admitted to hospital (Fig. 1). In many
cases, if risk assessment methods were more widely
applied, a substantial number of hospital admissions would
be avoided thereby reducing cost of care. Those individuals
not admitted could be safely and economically evaluated in
specialized multidisciplinary outpatient syncope clinics
[1,7e12].
This review focuses on improving understanding of
clinical and laboratory features that are useful for deter-
mining whether a patient with suspected syncope is best
admitted to hospital, or could be safely evaluated as anoutpatient. The ultimate goal is improved assessment of
prognostic risk at the time of initial patient presentation,
leading to more efficient and cost-effective subsequent
management.Syncope classification
The classification of syncope is mainly based on the under-
lying mechanisms that lead to the final event of transient
global hypoperfusion. A diagnostic classification of the cau-
ses of syncope modified from the European Society of Car-
diology (ESC) syncope practice guidelines [1] is summarized
in Table 1.Syncope evaluation
ED or clinic assessment of patients who present with pre-
sumed syncope may be challenging for several reasons. First,
the affected individual is usually asymptomatic on arrival and
as a result the physician is without direct ‘observation’ of the
episode and be sure. Second, the patient (especially if elderly)
may not be able to provide a detailed history. Third, even if the
event(s) have been witnessed, the observer may not be able to
recollect sufficient detail. Nevertheless, careful evaluation of
apparent syncope whether in the ED or a specialized syncope
clinic is crucial; only by identifying the specific cause can an
effective preventive treatment strategy be initiated. In this
regard, it is understood that most often, syncope is not an
immediately life-threatening condition, but one that may
nonetheless substantially diminish quality of life and lead to
physical injury.Risk of death and life-threatening events
Many syncope patients, especially young healthy individuals
with a normal ECG and without heart disease, do not
represent a worrisome prognostic subgroup and if further
evaluation is needed this can be undertaken in the outpa-
tient setting. Typically the large majority of these individuals
have one of the neurally-mediated reflex syncope syndromes
(i.e., vasovagal faint, post-micturition syncope, etc.). In such
cases mortality risk is low, but syncope recurrence leading to
injury and diminished quality-of-life issues may be impor-
tant considerations, along with potential adverse impact on
employment status and driving privileges. On the other
hand, even in apparently healthy individuals, the prognosis
of syncope is not always benign; this is especially the case in
Fig. 1 e Flow chart for diagnostic evaluation of patients who present to the emergency department (ED) or clinic with
transient loss of consciousness (TLOC)/syncope. Modified after Ref. [1].
Table 1 e A classification of the causes of syncope. VVS ¼ vasovagal syncope, CSS ¼ carotis sinus syndrome,
ANS ¼ autonomic nervous system, AV ¼ atrioventricular, VT ¼ ventricular tachycardia, SVT ¼ supraventricular
tachycardia, ICM ¼ ischemic cardiomyopathy, NICM ¼ non-ischemic cardiomyopathy, HCM ¼ hypertrophic
cardiomyopathy, ARVC: arrhythmogenic right ventricular cardiomyopathy.
Syncope: classification and principal causes
Neural reflex Orthostatic Cardiac arrhythmia Structural CV
- VVS
- CSS
- Situational
- Cough
- post micturition etc,
- Drug induced
- ANS failure
- Primary
- Secondary
- Bradycardia
- Sick sinus
- AV block
- Tachycardia
- VT
- SVT
- Channelopathies
- Aortic valvular stenosis
- ICM, NICM
- HCM, ARVC
- Pulmonary hypertension
- Aortic dissection
- Subclavian steal
z60% z15% z%10 z5
Unknown z10%
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alous coronary arteries, early stage cardiomyopathy) or
channelopathies (i.e., long QT syndrome [LQTS], Brugada
syndrome).
The presence and severity of co-existing structural heart
disease are the most important predictors of mortality risk in
syncope patients. In the European Evaluation of Syncope
Guidelines 2 Study and EGSYS-2 [13,14], among 398 patients
seen in the EDs of 11 Italian general hospitals, death of any
cause occurred in 9.2% patients over a mean follow-up of 614
days. Among all deaths, 82% of patients had an abnormal ECG
and/or heart disease. On the other hand, only 6 (3%) deaths
occurred in patients without abnormal ECG and/or heart dis-
ease (i.e., negative predictive value, 97%).
Key clinical factors favoring cardiac causes of syncope or
death were [13]: age >45 years, history of congestive heart
failure, history of ventricular arrhythmias, and abnormal ECG
(other than nonspecific ST changes). Arrhythmias or death
within 1 year occurred in 4e7% of patients without any risk
factors and progressively increased to 58e80% in patientswith
three or more factors. The 1-year mortality of patients with
cardiac syncope is consistently higher (18e33%) than patients
with non-cardiac causes (0e12%) or unexplained syncope (6%)
[13,14].
In the Osservatorio Epidemiologico sula Sincope nel Lazio
(OESIL) study [15], the 4 patient characteristics that were
associated with adverse outcome: age >65 years, a clinical
history of cardiovascular disease, syncope without apparent
warning symptoms, and an abnormal ECG [10]. In this study a
risk score was proposed to assist assessment of the medical
‘urgency’ associated with the patient's presentation, with
each characteristic scoring one point. One-year mortality
increased with increasing score (0% for a score of 0; 0.8% for 1
point; 19.6% for 2 points; 34.7% for 3 points; 57.1% for 4 points;
p < 0.0001 for trend).
While patients with cardiac syncope have higher mortality
rates compared to patients with syncope of non-cardiac or
unknown causes, cardiac syncope patients do not necessarily
exhibit a higher mortality compared with patients having
similar degrees of heart disease [16e20]. Thus, for the most
part, it is the severity of structural heart disease that counts,
albeit with some important exceptions, including:
i. severe aortic stenosis (average survival without valve
replacement of 2 years),
ii. hypertrophic cardiomyopathy in which syncope is a
predictor of increased sudden death risk,
iii. heart failure and severe left ventricular dysfunction,
and
iv. syncope in the setting of one of the channelopathies
(e.g., Brugada syndrome, long QT syndrome [LQTS]), or
in the presence of arrhythmogenic right ventricular
cardiomyopathy (ARVCM).
Older age, and associated frailty also contribute impor-
tantly to increased risks accompanying syncope. Falls and
orthopedic complications substantially increase mortality.
Thus, orthostatic hypotension, a condition more prevalent
in the elderly than in the young, is associated with a 2-fold
higher risk of death compared with the general population.In part associated co-morbidities may be contributing, but
in addition complications of falls such as major limb frac-
tures are associated with substantial mortality in the
elderly.Short-term risk
The risk of life-threatening conditions in the few days or
weeks after syncope is themain trigger for immediate hospital
admission. In many cases, admission might be avoided by
careful risk assessment at the time of presentation. The pre-
sumption that an immediate in-hospital evaluation improves
long-term clinical outcome has never been demonstrated, and
admission to units not experienced in the syncope evaluation
is likely to be accompanied by the high costs associated with
excessive use of low yield tests (e.g., head CT/MR, EEG, con-
ventional Holter monitor). Alternative strategies such as
referral to a specialized outpatient 'blackout' or syncope clinic
may be superior especially if immediate high mortality risk is
excluded by careful risk assessment.
Several studies have evaluated the short-term risk of death
(usually defined as <1 month), injury, or syncope recurrence
after initial presentation (Table 2).
i) San Francisco Syncope Rule [21]
An abnormal ECG (i.e., new changes or non-sinus rhythm),
shortness of breath, systolic blood pressure  90 mm Hg,
hematocrit  30% and congestive heart failure (by history or
examination) predicted the likelihood of a serious adverse
event within 7 days of ED evaluation. Serious adverse events
were defined as death, myocardial infarction, arrhythmia,
pulmonary embolism, stroke, subarachnoid hemorrhage,
significant hemorrhage, or any condition causing a return ED
visit and hospitalization for a related event. The rule was
determined to exhibit a sensitivity of 98% and a specificity of
56%. However, these results could be only partially confirmed
by 3 validation studies that showed a high rate of both false
positive and false negative results.
ii) ROSE rule [22]
The ROSE rule was a single center (Edinburgh, UK) study
designed to derive and validate clinical decision rules for
syncope assessment; specifically these rules consisted of:
medical history, physical findings, ECG, and biochemical
markers. Brain natriuretic peptide (BNP) 300 pg/mL, positive
fecal occult blood, hemoglobin 90 g/L, oxygen saturation
94%, Q wave on ECG, chest pain at the time of syncope and
bradycardia <50 bpm predicted the likelihood of serious
adverse event within one month of ED evaluation. Serious
adverse events were defined as death, acute myocardial
infarction, life-threatening arrhythmia, decision to implant a
pacemaker or cardiac defibrillator within one month, pulmo-
nary embolus, cerebrovascular accident, hemorrhage
requiring a blood transfusion, acute surgical procedure or
endoscopic intervention. At one month, 7.1% of validation
cohort met an end-point, with ROSE rule sensitivity and
specificity being 87.2% and 65.5% respectively.
Table 2 e Principal short-term syncope risk stratification
studies. ECG¼ electrocardiography, BP¼ blood pressure,
CHF¼ congestive heart failureSOB¼ shortness of breath,
BNP ¼ brain natriuretic peptid, ED ¼ emergency
department, CNS ¼ central nervous system.
Study (N) Markers Follow up & adverse
outcomes, frequency
San Francisco Rule
(Derivation, 684)
- Abnormal ECG
- Low BP
- CHF, SOB
- Hematocrit <%30
7 days
79, 11.5%
Rose Rule
(Derivation, 550
Validation,550)
- Elevated BNP
- Chest pain
- Abnormal ECG
- Fecal blood
1 month
Derivation, 40, 7.3%
Validation, 39, 7.1%
StePs (N ¼ 676) - Abnormal ECG
- Trauma
- No warning, Male
gender
10 days
41, 6.1%
Boston (N ¼ 293) - Acute coronary
syndrome
- Conduction
system
disease
- Cardiac disease
history
- Family history of
sudden death
- Volume depletion
- Persistent
abnormal vital
signs in ED
- Primary CNS
event
1 month
68, 23%
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The STePS study screened over 2700 patients with pre-
sumed syncope at 4 general hospitals in the Milan region of
northern Italy during the first half of 2004. A total of 676 pa-
tients were included in the study. Statistically significant in-
dependent risk factors for short-term (within 10 days) adverse
outcomes (defined as cardiopulmonary resuscitation, pace-
maker or defibrillator implant, intensive care unit admittance
and early readmission to hospital) were: Age >65 years, male
gender, structural heart disease, heart failure, trauma,
absence of symptoms of impending syncope, and an
abnormal ECG. However, owing to the relative low rate of
events, the clinical utilitywas hampered by a very lowpositive
predictive value that ranged from 11% to 14%.
iv) Boston study [24]
The Boston study utilized a pre-determined decision rule to
assess risk in consecutive adult patients presenting to the ED
with syncope. The clinical rule deemed to increase the 30
day risk of an adverse outcome or critical intervention
comprised any one of the following clinical factors: 1) Acute
coronary syndrome, 2) Conduction system disease, 3) History
of cardiac disease, 4) Valvular heart disease, 5) Family history
of sudden death, 6) Abnormal vital signs in ED, 7) Volume
depletion, 8) Primary CNS event. Follow-up was complete in
293 patients. Adverse outcomes or interventions occurred in68 (23%) patients. The rule identified 66/68 patients with an
end-point (sensitivity 97%, specificity 62%.)
Based on the findings derived from the studies mentioned
above, the risk factors noted to be consistently associatedwith
adverse outcomes are:
i. Acute coronary syndrome associated with syncope
ii. Evidence or history of CHF
iii. History of structural heart disease
iv. Abnormal ECG
v. Anemia
vi. Hemodynamic instabilityLonger-term risk
The risk of an adverse outcome one-year or more after a
syncope event has been the subject of a number of risk
assessment reports (Table 3).
i) Martin et al. [25]
Martin et al. examined in a prospective fashion two sets
of patients attending an urban University medical center ED
in Pittsburgh, Pennsylvania. The first group of 252 syncope
patients was used to derive a risk assessment scheme, and
the second set (n ¼ 374) was used as a validation cohort. The
objective was to identify predictors of arrhythmia or mor-
tality at 1-year follow-up. Four risk factors were identified
following multivariate analysis: 1) abnormal ECG (odds ratio
[OR] 3.2, 1.6e6.4) defined as rhythm abnormalities, conduc-
tion disorders, hypertrophy, old myocardial infarction, or
atrioventricular [AV] block, 2) history of ventricular
arrhythmia (OR 4.8, 1.7e13.9), 3) history of congestive heart
failure (OR 3.1, 1.3e7.4), or 4) age >45 years (OR 3.2, 1.3e8.1).
These risk factors were found to be predictors of severe
arrhythmia (sustained ventricular tachycardia, symptomatic
supraventricular tachycardia, pauses >3 s, AV block, pace-
maker malfunction) or 1-year mortality. Arrhythmias or
death at <1 year occurred in 7.3% (derivation cohort) to 4.4%
(validation cohort) without any risk factors, versus 80.4%
(derivation cohort) to 57.6% (validation cohort) with three or
four risk factors.
ii) STePS study [23]
The one-year mortality in the STePS cohort was 6% with
the cause of most deaths being undetermined. An additional
3.3% of the population exhibited other adverse outcomes. By
multivariable analysis, long-term adverse outcome was
associated with age >65 years, history of neoplasm, cerebro-
vascular disease, structural heart disease, or ventricular
arrhythmia.
iii) OESIL study [15]
The one-year predictors for mortality in OESIL were age >65
years, history of cardiovascular disease, lack of prodrome and
an abnormal ECG defined as rhythmabnormalities, conduction
Table 3 e Principal studies of Longer-term Syncope Risk
Stratification ECG ¼ electrocardiography,
CHF ¼ congestive heart failure, SOB ¼ shortness of
breath, CV ¼ cardiovascular.
Study Risk markers
Martin et al. - Abnormal ECG,
- CHF, SOB
- Ventricular arrhythmia
- Age > 45
OESIL score - Abnormal ECG,
- Age > 65
- History of CV disease
- No warning
EGSYS Palpitation before event
Abnormal ECG
Heart disease
Syncope during effort
Syncope supine (2 pts)
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acute ischemia or AV block. In the OESIL risk assessment,
mortality within one year increased progressively from 0% for
no factor, to approximately 57% for 4 factors.
iv) EGSYS score [13]
Six predictive factors were identified. Heart disease was
deemed to be present if there was a history of or evidence for
ischemic heart disease, valvular dysfunction, myocardio-
pathies, congenital heart disease or congestive heart failure.
The ECG was considered abnormal if there was sinus brady-
cardia, AV block greater than first degree, bundle branch
block, acute or old myocardial infarction, supraventricular or
ventricular tachycardia, left or right ventricular hypertrophy,
ventricular preexcitation, long QT or Brugada pattern. The
EGSYS score predicted a 2-year mortality of 2% in those with a
score <3, and 21% for a score 3.Limitations of current risk stratification schemes
Despite the considerable effort that has been directed toward
devising the various syncope risk stratificationmethods, none
has as yet been met by consensus approval and none can
replace a comprehensive history obtained and interpreted by
an experienced clinician. In some instances, the proposed risk
stratification tool is too broad a brush and ‘defines’ an
excessively large and non-specific patient population at risk
(e.g., an abnormal ECG, age >65 years). In other instances the
proposed risk stratification tool is not readily available on
short notice (e.g., echocardiography, BNPmeasurement), or in
other instances the tool may predict mortality of other cause
unrelated to syncope (e.g., history of neoplasm).
Given the ongoing uncertainty facing ED and urgent care
clinic physicians when encountering patients with presumed
syncope, certain recommendations may be worthy of
consideration:
1. Detailed training in key aspects of medical history taking
required for assessment of syncope patients, and in
appropriate selection of laboratory testing,2. Provision of observation units in the ED or hospital where
patients may remain until seen promptly by a syncope/
TLOC consultation team. The latter may be a subset of
another service particularly interested in syncope/TLOC
such as Cardiology, Neurology, Geriatrics or Internal Med-
icine. In addition, these specialties may work together
resulting in a multidisciplinary approach to the patient
(i.e., a virtual ‘Syncope Management Unit’, SMU),
3. Initiation of an outpatient syncope/TLOC clinic for rapid
follow-up assessment discharged from the ED. This same
service might additionally provide prompt consultation in
the ED during daytime hours.Summary
Syncope has many possible causes ranging from relatively
benign to potentially life-threatening; sorting through the
possibilities may not feasible given time limitations in an ur-
gent care setting. Therefore, the physician almost always
must determine whether the affected individual needs in-
hospital evaluation or can be safely referred to an outpatient
syncope evaluation clinic. In general, several key issues
determine the need for hospitalization:
i. the patient's immediatemortality risk and risk potential
for physical injury (e.g., falls risk) based on the risk
stratification steps outlined above,
ii. the patient's ability to care for him/herself (e.g., risk of
falls and injury), and
iii. whether certain treatments inherently require in-
hospital initiation (e.g., pacemaker implantation).
In instances when the etiology of syncope has been
diagnosed with confidence at the initial clinical evaluation
in the urgent care setting, these questions are readily
addressed and the appropriateness of hospitalization versus
timely outpatient evaluation is clear. Thus, for example,
patients with accompanying complete heart block, ventric-
ular tachycardia, acute aortic dissection, hypertrophic car-
diomyopathy, evident or suspected channelopathy (e.g.,
long QT syndrome, Brugada syndrome) or pulmonary em-
bolism, should be admitted, whereas most vasovagal faint-
ers (which comprise more than half of all cases) can be sent
home after careful discussion of the nature of the problem
and simple preventative maneuvers (e.g., hydration, avoid-
ance of hot crowded environments, etc.), and if necessary
clinic follow-up is arranged. In those cases in which the
diagnosis is uncertain, risk stratification schemes such as
those summarized above become more essential. In this
regard, increasing age, abnormal ECG, and a history of car-
diovascular disease (especially ventricular arrhythmia or
heart failure), appear to be relatively consistent predictors of
increased susceptibility to worrisome sustained arrhythmia
and/or mortality. Other factors that also seem to be relevant
include syncope occurring without apparent warning or
during effort (i.e., ‘in full flight’) or while the patient was
supine (suggests a severe arrhythmia). Further, most deaths
and serious outcomes seem to be correlated to the severity
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u r n a l 1 5 ( 2 0 1 5 ) 1 0 3e1 0 9 109of underlying disease rather than to syncope per se. How-
ever, as noted earlier, at present no single risk assessment
protocol appears to be satisfactory for universal application,
and the development of a consensus recommendation is an
essential next step [7].r e f e r e n c e s
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